Navigation Links
DiagnoCure announces optimization of entreprise structure
Date:2/15/2010

                   - Taking Steps to Preserve Liquidity -

QUEBEC CITY, Feb. 15 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, today announced changes to its enterprise structure to optimize its growth potential. Henceforth, the Company will be comprised of two business segments: (1) administrative headquarters in Quebec City, holder of the PCA3, GCC and Shc patents, and (2) DiagnoCure Oncology Laboratories (DOL), DiagnoCure's U.S. wholly-owned sales, marketing and service laboratory operations. The Company will focus its product development efforts on the pivotal clinical study, called VITAR, designed to confirm the clinical value of the Previstage(TM) GCC Colorectal Cancer Staging Test on lymph nodes. As part of the realignment of activities, John Schafer, President and CEO of DiagnoCure, will relocate to the U.S., where he will lead the commercialization activities related to Previstage(TM) GCC, and the effort to grow the DOL franchise into a profitable full service specialty laboratory featuring diagnostic tests for colorectal cancer. Dr. Yves Fradet, currently Chairman of the Board, will also become President of DiagnoCure, Inc. effective today.

This realignment, coupled with a selective reduction in personnel that maintains all of the Company's core competencies, is expected to allow DiagnoCure to preserve all the liquidity necessary to support its operations until the sales of Previstage(TM) GCC ramp up and the PCA3 test is approved for sale in the U.S. This approval is now anticipated to occur in 2011, following the expected 2010 submission of a premarket approval application (PMA) by DiagnoCure's partner, Gen-Probe, to the U.S. Food and Drug Administration (FDA).

"The need for specialty
'/>"/>

SOURCE DiagnoCure Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. DiagnoCure announces fourth quarter 2009 and year-end results
2. /R E P E A T -- DiagnoCure signs distribution agreement in the UK for its colorectal cancer test/
3. DiagnoCure signs distribution agreement in the UK for its colorectal cancer test
4. DiagnoCure to host Q2 2009 earnings conference call and webcast
5. DiagnoCure announces first quarter 2009 results
6. New website empowers colorectal cancer patients when discussing critical treatment decisions - DiagnoCure launches www.mypersonalcancerdiagnosis.com
7. DiagnoCure to Host Q1 2009 Earnings Conference Call and Webcast
8. Major study on DiagnoCures GCC biomarker published in Jama
9. DiagnoCure announces fourth quarter 2008 and year-end results
10. DiagnoCure announces fourth quarter and full year 2008 earnings conference call and webcast
11. DiagnoCure to webcast presentation at the Piper Jaffray Health Care Conference on December 3, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... (PRWEB) July 23, 2014 SpaRoom® ... , SpaRoom’s top product and premier diffuser, is now ... feel and an improved motor for maximum quality. The ... is now available on SpaRoom.com for $60 along with ... safe, ultrasonic pulsations to create a long-lasting, tranquil mist. ...
(Date:7/23/2014)... July 23, 2014 Relias Learning, the ... health and human services markets, continued to expand its ... record growth in its core markets and further expansion ... the use of SaaS-based training solutions accelerate across a ... Relias Learning. “Health and human services organizations, in particular, ...
(Date:7/23/2014)... 2014 Throughout the month of July, LunaDress, ... of new items. Also, it is hosting a couple of ... collection of short summer beach wedding dresses for the ... styles in it. Additionally, these outfits are now offered with ... “As one of the world’s leading suppliers, LunaDress is always ...
(Date:7/23/2014)... Princeview Dental ( http://www.PrinceviewDental.com ), one ... of having a complete oral exam. , “Oral exams ... oral health care, as there are so many benefits ... founder of Princeview Dental. “Dentists are trained to detect ... Just by observing the inside of the mouth, we ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Daily Face & ... cheaper and safer alternative to Botox called Stem Cell ... is an anti-aging product used to help people smooth, tone, ... Serum can be used as a safe alternative to Botox, ... have any toxins or health risks as opposed to Botox. ...
Breaking Medicine News(10 mins):Health News:SpaRoom® Unveils New Sleek Color, Improved AromaMist™ 2Health News:Relias Learning announces Q2 results - continues record growth and new market expansion 2Health News:LunaDress Continues To Enrich Product Line By Offering Short Summer Beach Wedding Dresses 2Health News:Princeview Dental, One of Etobicoke’s Trusted Dental Clinics, Addresses the Need to Have Complete Oral Exams 2Health News:Local Denver Skin Care Company Releases Safer Alternative to Botox 2
... says that a serving or two of dark or bitter ... comes as a breath of fresh “sweet” air from Swiss ... at Zurich's University hospital. They investigated and found after tests ... cocoa content (75 per cent) improved their blood circulation "significantly". ...
... Executive Director Peter Ellis has revealed that a version of the ... dysfunction market is much larger when compared to that of men, ... pill for that, according to Ellis. The desire, arousal and pain ... the pill, which will make it all the more difficult to ...
... flight attendants working for a National European Airline from ... they rate their health as poor when they have ... to the other women who are working with the ... attention, being proposed, ogled at, subjected to offensive remarks ...
... brandy per day reportedly has a similar antioxidant potential which ... belonging to the Monash University. This does not mean that ... can continue along with drinking brandy. ,Red ... arteries are de-sludged by its consumption in addition to it ...
... at risk for high blood pressure, heart disease and ... current issue of the American Journal of Preventive Medicine. ... blood pressure, or hypertension, generally consume less sodium than ... than recommended levels, according to lead researcher Umed Ajani, ...
... The National Institutes of Health (NIH) has revealed that the ... the youngsters in the US. There has however been an ... purposes. The University of Michigan conducted the 2005 Monitoring the ... overall results were good. , ,It found that cigarette ...
Cached Medicine News:Health News:Americans Consume Far Too Much Salt and Sodium 2Health News:Drug Use On The Decline Among US Youth 2
(Date:7/23/2014)... July 23, 2014 Global healthcare ... is facing currency headwinds, increased price competition and supply ... Andrew Witty points out that the company is ... as reason to be confident about long-term prospects as ... growth. CFO Simon Dingemans adds ...
(Date:7/23/2014)...  Dompe, a leader in R&D for new therapeutic solutions ... Human Nerve Growth Factor) has been designated as an orphan ... The candidate drug, developed by the research of ... treatment of neurotrophic keratitis, a degenerative corneal disease that affects ... currently without a cure. This is the second orphan drug ...
(Date:7/23/2014)... -- Pelvalon, Inc. is making its clinical debut at ... D.C. with the presentation of results from ... Control (VBC) System.  Holly E. Richter , Ph.D, ... Reconstructive Surgery at the University of Alabama at Birmingham ... Surgeons (SGS), served as the National Principal Investigator and ...
Breaking Medicine Technology:Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4Pelvalon Announces Results from the LIFE Pivotal Trial at the 2014 AUGS/IUGA Conference 2
...  Everett Laboratories, Inc., Women,s Health Care company, leader ... that it had filed a patent infringement lawsuit ... the United States District Court of New Jersey ... company.  The lawsuit asserts, among other things, that ...
... 23, 2012 HeartWare International, Inc. (NASDAQ: ... invasive, miniaturized circulatory support technologies revolutionizing the treatment of ... an expanded European label for long-term use of the ... of death from refractory, end-stage heart failure. ...
Cached Medicine Technology:Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc. 2HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure 2HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: